Skip to main content

RevCore for In Stent Thrombosis

Recruiting · NCT06394739

Conditions: In-stent Thrombosis

At a glance

Research payments reported, 2025
$281,590
U.S. investigators named
13
Sites paid
16
Planned or actual enrollment
100

About the trial

Sponsor
Inari Medical
Tested
Thrombectomy (device)
Dates
Started 2024-09-09; completion 2028-04
Results posted
Not yet

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

From ClinicalTrials.gov, last updated 2026-10-27. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Stryker Corporation reported $281,590 in research payments for this study in 2025 (117 payments).

Products named: Flowtriever Catheter, S, Revcore Thrombectomy Catheter

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Trustees of the University of Pennsylvania $41,796
  • Yale University $39,958
  • University of Washington Medical Ctr, WA $35,131
  • Ahn Research Institute $30,521
  • University of Maryland Baltimore $26,291
  • Sentara Hospitals $18,674
  • Medstar Health Research Institute $18,457
  • West Virginia University Research Corporation $15,975
  • Uh Cleveland Medical Center $12,463
  • El PAso Cardiology Associates PA $10,397
  • University of Maryland School of Medicine $10,243
  • HCA Research Institute LLC $7,401
  • Yale-New Haven Hospital, CT $5,063
  • Abdullah Shaikh $4,000
  • Thomas Jefferson University $3,600
  • The Ohio State University $1,620

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.